ATLANTA, Dec. 22, 2016 -- December 22, 2016 – UPS (NYSE:UPS) today said it completed the acquisition of Marken, a global provider of supply chain solutions to the life sciences industry and leader in clinical trials material storage and distribution. The transaction, which closed on Wednesday, makes Marken a wholly owned subsidiary of UPS and provides UPS with growth opportunities across the life sciences customer base.
“Healthcare logistics is a strategic market for UPS. Our acquisition of Marken strengthens our portfolio and demonstrates our commitment to customers and the healthcare industry,” said Teresa Finley, UPS Chief Marketing and Business Services Officer. Wes Wheeler will continue as CEO of Marken, reporting to Teresa Finley.
Terms of the purchase were not disclosed.
About UPS
UPS (NYSE: UPS) is a global leader in logistics, offering a broad range of solutions including transporting packages and freight; facilitating international trade, and deploying advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. The company can be found on the web at ups.com® and its corporate blog can be found at longitudes.ups.com. To get UPS news direct, visit pressroom.ups.com/RSS or follow @UPS_News.
About Marken
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 45 locations worldwide for clinical trial material storage and distribution. Marken’s more than 680 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry. For more information on services and locations, visit www.marken.com.
Kyle Peterson (404) 828-4626 [email protected] Christine Noble (919) 474-6890 [email protected]


LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Robinhood Expands Sports Event Contracts With Player Performance Wagers 



